InnovaDerma expects revenue and profits for the full year to 30 June to be well ahead of expectations.
The company's pre-close trading update said that overall revenues were expected to increase by 80% on a constant currency basis to approximately £9 million.
It said: "Revenues have been bolstered by the exceptional performance of Skinny Tan through the company's fast-expanding direct to consumer platform and retail channels, with the brand achieving the highest-monthly revenues for four months in the second half of financial year 2017.
"Underlying profit before tax is expected to increase by 355% to approximately £1.28 million excluding one-off costs (2016: £0.281 million on a constant currency basis) driven by a more efficient supply chain which has led to an improvement in gross margin of approximately 62% (2016: 57.4%), up 400 bps.
"The Group has maintained a strong balance sheet."